assay validation

Ampersand Biosciences develops, manufactures, and validates multiplex immunoassays for the Luminex platform, along with proteins and antibodies. Founded in 2015 and based in Lake Clear, New York, it offers custom assay development and biomarker sample testing for drug discovery and pre-clinical research, including cytokine panels for ferret, hamster, mouse, rat, canine, and human samples.

antibody productionassay scale-up manufacturingbiomarker sample testingELISA developmentLuminex multiplex assay developmentrecombinant protein production

Ansh Labs is a developer and manufacturer of immunoassay reagent test kits used to advance target discovery, therapeutic development, biomedical research, and clinical diagnostics. The company serves life science researchers, physician researchers, hospitals, commercial laboratories, and public health agencies, and its products support research in reproductive function, pregnancy, central nervous system, atherosclerotic cardiovascular disease, and oncology. Ansh Labs is now part of the VION Biosciences family of companies.

antibody development and screeningassay developmentassay optimizationCLIAELISAimmunoassay developmentimmunofluorescenceimmunohistochemistryluminogenic microplatemonoclonal antibody developmentneutralizing antibodywestern blot

Arkana Laboratories is a specialized renal and neuromuscular pathology laboratory based in Little Rock, Arkansas, focused on improving patient care. It interprets the largest number of renal biopsies in the U.S. at 23,000+ annually and provides same-day turnaround on many pathology services.

APOL1 genotypingbiorepositoryelectron microscopyenzyme histochemistryimmunofluorescenceimmunohistochemistrylight microscopyneuropathology analysisrenal biopsy interpretation

Biodesix is a diagnostic solutions company that provides advanced diagnostic tests and custom development services. Its tests support clinical decisions for patients with lung disease, and its development services support biopharmaceutical, life sciences, and research institutions in developing diagnostic tests, tools, and therapeutics. The company operates two certified laboratories and uses its proprietary Diagnostic Cortex bioinformatics platform.

bioinformatics (Diagnostic Cortex platform)biomarker discoveryclinical trial sample testingcustom assay developmentddPCRgenomic testing and monitoringmulti-omics integrationNGSproteomic testingspatial proteomics with MALDI-IHCspecimen collection kit manufacturing

Bio-Val Consulting, LLC (BVC) is a woman-owned small business founded in 2013 by CEO Kristin H. Clement, Ph.D., dedicated to helping clients navigate assay development and validation and meet regulatory compliance for bioanalytical needs. It offers consulting on quantitative MOA-based bioassays supporting drug research and development, including antibody screening, characterization, potency and stability testing.

antibody purificationassay developmentbinding assayscAMP stimulation assayscell-based assaysddPCRECL (Meso Scale Discovery)ELISAELISpotflow cytometrylateral flow assay developmentneutralization assaysPCRphagocytosis assaysqPCRSDS-PAGE/Western Blot

ExciPlex, Inc. invents diagnostic assays, builds detection systems, and supplies critical reference materials for agricultural and environmental monitoring. The company specializes in natural toxins, supplying high purity toxins and complex small molecules, and provides specialty chemical production for high performance diagnostics. It also offers CRO and consulting services to biotech, agtech, and life sciences companies, and develops portable spectroscopic instrumentation.

assay developmentconjugation chemistryconsultingdiagnostic assay inventionlibrary design and synthesisportable spectroscopy instrumentationreaction optimizationsynthetic chemistrytoxin purification

Foundation Medicine is a global, patient-focused precision medicine company delivering high-quality, transformative diagnostic solutions in cancer and other diseases. Founded in 2010, it developed one of the first standardized comprehensive genomic profiling (CGP) platforms using next-generation sequencing to analyze a broad panel of genes and detect all four classes of genomic alterations. It provides tests and solutions across the patient experience, from diagnosis to treatment selection to ongoing monitoring, and partners with biopharmaceutical compan

AI-enabled toolscompanion diagnostic developmentcomprehensive genomic profiling (CGP)IHC testingnext-generation sequencing